Cite

HARVARD Citation

    Provencio, M. et al. (n.d.). 473PASTRIS global real world study of osimertinib in patients (pts) with EGFR T790M non-small cell lung cancer (NSCLC): Subpopulation analyses. Annals of oncology. p. . [Online]. 
  
Back to record